The biggest obstacles to clinical research today are the legacy business models we’ve built to support functional outsourcing to multiple vendors. To save time, money, and resources, we have standardized our current system — locking ourselves into an approach that is not compatible with progressive change. Now, drug sponsors and CROs are ill-equipped to adopt new methods and we are squelching opportunities to radically change the way research is performed.

Join our CEO, Ed Seguine, for a discussion on the dynamic, fundamental shifts our industry needs to make to support positive disruption across the research paradigm, streamline development, and escape the innovation paradox.

 

In addition, stop by our booth or set up a meeting to learn how our configurable eSource technology platform can empower your organization to make better informed decisions, improve compliance, and identify issues faster.